ZP-10068

N/A

Report date: 2024/06/13 13:47:45
NME

Base Information

Drug NameZP-10068
Drug Alias NameZP-10068ZP10068
ClassificationSmall molecules > Synthetic peptide
Mechanisms of ActionComplement C3 inhibitors
TargetsComplement C3
Therapy Area/IndicationsInflammation
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryDenmark
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesZealand Pharma A/S
China Registration ClassN/A

Develop Information

Active CompaniesZealand Pharma A/S
Inactive CompaniesAlexion Pharmaceuticals Inc
Active IndicationsInflammation
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A